期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Smac蛋白对C6胶质瘤细胞的影响 被引量：2

Influence of Smac protein on C6 brain glioma cells
原文传递
导出
摘要 目的观察Smac蛋白对C6胶质瘤细胞的影响。方法以不同浓度（1．5×10^-6～1．5×10^-2）g／L作用于C6胶质瘤细胞24～72h，采用噻唑蓝（MTT）比色法检测细胞增殖抑制率，流式细胞术（FCM）检测细胞凋亡率和细胞周期的影响。结果（1）Smac能以剂量和时间依赖方式抑制C6胶质瘤细胞的增殖，在终质量浓度为1．5×10^-2g／L，72h时抑制率达（57．13±1．41）％，24h半数抑制浓度（IC50）为：1．34×10^-2g／L，其差异具有统计学意义（P〈0．01）；（2）经流式细胞仪分析，Smac蛋白能诱导C6胶质瘤细胞发生凋亡，此作用呈剂量和时间依赖性；（3）Smac蛋白可将C6胶质瘤细胞阻滞在G0／G1期。结论Smac蛋白能够显著抑制C6胶质瘤细胞生长，诱导其凋亡，其机制可能与C6胶质瘤细胞周期阻滞在G0／G1期有关。 Objective To study the influence of Smac protein on C6 brain glioma cells. Methods The C6 brain glioma cells were treated with Smac protein at different concentrations （ 1.5 × 10^-6 - 1.5×10^-2 ） g/L for 24-72 h. MTT assay was used to measure the inhibition rate of cell proliferation. The apoptosis rate and cell cycle were detected by flow eytometry. Results Smac protein inhibited the proliferation of C6 brain glioma cells in a dose- and time-dependent manner,the inhibition rate was （57.13 ± 1.41 ）% at 72 h with Smac of 1.5 × 10^-2 g/L. The IC50 of Smac at the 24th h was 1.34×10^-2 g/L. Smac protein induced the apoptosis of C6 brain glioma cells in a dose- and time-dependent manner, and Smac protein could block C6 cells in G0/G1 phase. Conclusion Smac protein could significantly inhibit the growth and induce the apoptosis of C6 cells by blocking cell cycle in G0/G1 phase.
作者 夏开来 黄书岚 孙建波 葛剑
机构地区 武汉大学人民医院神经外科
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第5期621-623,共3页 Chinese Journal of Experimental Surgery
关键词 胶质瘤 脱噬作用 细胞周期 Glioma Apoptosis Cell cycle
分类号 R739.41 [医药卫生—肿瘤] R742.1 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献9

  • 1Du C, Fang M, Li Y. Smae, a mitoehondrial protein that promotes cytochrome c-dependent caspase activation by eliminating lAP inhibition. Cell, 2000,102 : 33 -42.
  • 2Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing lAP proteins. Cell,2000,102:43-53.
  • 3马廉亭.脑胶质瘤实验研究的现状与展望[J].中华实验外科杂志,2001,18(6):490-490. 被引量：16
  • 4黄强,浦佩玉,夏之柏,蒋元文,尤永平,张云亭,王春燕,王广秀.连接蛋白43联合自杀基因治疗胶质瘤的研究[J].中华实验外科杂志,2003,20(3):285-285. 被引量：6
  • 5Kashkar H,Haefs C. XIAP-mediated Caspase inhibition in Hodgkin' s lymphoma-derived B ceils. J Exp Med,2003,198 : 3412-3447.
  • 6Arnt CR, Kaufmann SH. The saintly side of Smac/DIABLO : giving anticancer drug2induced apoptosis a boost. Cell Death Differ,2003,10: 1118-1120.
  • 7Jia L, Patwari Y, Kelsey SM, et al. Role of Smac in humanleukaemic cell apoptosis and oroliferation. Oncogene,2003,22 : 1589-1599.
  • 8Vogler M, Giagkousiklidis S, Genze F, et al. Inhibition of clonogenic tumor growth : a novel function of Smaccontributing to its antitumor activity. Oncogene, 2005,24 : 7190 -7202.
  • 9张翠娟,周庚寅,喻芳,李丽,林晓燕,马超.5-脱氧杂氮胞苷对HepG2肝癌细胞恶性表型及caspase-3和bcl-2表达的影响[J].临床与实验病理学杂志,2005,21(1):103-106. 被引量：6

二级参考文献11

  • 1Yang B,Guo M,Herman JG,et al. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma[J]. Am J Pathol,2003,163(3):1101-7.
  • 2Hui AB,Lo KW,Kwong J,et al. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma[J]. Mol Carcinog,2003,38(4):170-8.
  • 3Astuti D,Da Silva NF,Dallol A, et al. SLIT2 promoter methylation analysis in neuroblastoma,Wilms' tumour and renal cell carcinoma[J]. Br J Cancer,2004,90(2):515-21.
  • 4Shim YH,Park HJ,Choi MS,et al. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma[J]. Mod Pathol,2003,16(5):430-6.
  • 5Herman JG,Latif F,Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma[J]. Proc Natl Acad Sci USA,1994,91(21):9700-4.
  • 6Ribeiro-Filho LA,Franks J,Sasaki M,et al. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer[J]. Mol Carcinog,2002,34(4):187-98.
  • 7Jones PA,Laird PW. Cancer epigenetics comes of age[J]. Nat Genet,1999,21(2):163-7.
  • 8Segura-Pacheco B,Trejo-Becerril C,Perez-Cardenas E, et al. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy[J]. Clin Cancer Res,2003,9(5):1596-603.
  • 9Krajewska M,Wang HG,Krajewski S,et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3),a cell death protease[J]. Cancer Res,1997,57(8):1605-13.
  • 10Fujikawa K,Shiraki K,Sugimoto K,et al. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma[J]. Anticancer Res,2000,20(3B):1927-32.

共引文献23

同被引文献29

  • 1Hanahan D, Weinberg RA. The halhnarks of cancer. Cell ,2000,100:57-70.
  • 2DU C, Fang M, Li Y, et al. Smac, a mito- chondrial protein that promotes cytochrame dependent caspase activation by elimina- tion lAP inhibition. Cell, 2000, 102 : 33- 42.
  • 3Verhagen AM, Ekent PG, Pakusch M, et al. Identification of DIABO, a mammalian protein that promotes apoptosis by binding to and antagozing IAP proteins. Cell, 2000,102:43-55.
  • 4Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis, 2007,12 : 1543- 1568.
  • 5Wu H,Tschopp J, Lin SC, et al. Smac mi- metics and TNFcL: a dangerous liaison. Ce11,2007,131:655-658.
  • 6Fulda S, Wick W, Weller M, et al. Smac agonist sensitizes for Apo2L/TRAIL or an- ticancer drug induced apoptosis and in- duces regression of malignant gliamain in vivo. Nat Med,2002,8 : 808-815.
  • 7Lu J,Bai L,Sun H,et al. SM-164:a no- vel, bivalent Smac mimetic that induces apoptosis and tumor regression by concur- rent removal of the blockade of cIAP-1/2 and XIAP. Cancer Res, 2008,68 : 9384- 9393.
  • 8Li W, Li B, Giacalone NJ, et al. BV6, an IAP antagonist, activates apoptosis and en- hances radiosensitization of non-small cell lung carcinoma in vitro. J Thorac Oncol, 2011,6 : 1801-1809.
  • 9Mllller-Sienerth N, Dietz L, Hohz P, et al. SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-de- rived dendritic cells. PLoS One, 2011,6 : e21556.
  • 10Lopes RB, Gangeswaran R, McNeish IA, et al. Expression of the IAP protein family is dysregulated in pancreatic cancer ceils and is important for resistance to chemo- therapy. Int J Cancer, 2007, 120: 2344- 2352.

引证文献2

二级引证文献1

中华实验外科杂志
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部